38.03
Precedente Chiudi:
$38.06
Aprire:
$38.06
Volume 24 ore:
264.19K
Relative Volume:
0.46
Capitalizzazione di mercato:
$1.89B
Reddito:
$3.53B
Utile/perdita netta:
$30.99M
Rapporto P/E:
62.00
EPS:
0.6134
Flusso di cassa netto:
$154.99M
1 W Prestazione:
+0.53%
1M Prestazione:
+1.49%
6M Prestazione:
+62.24%
1 anno Prestazione:
+30.73%
Astrana Health Inc Stock (ASTH) Company Profile
Nome
Astrana Health Inc
Settore
Industria
Telefono
(626) 282-0288
Indirizzo
1668 S. GARFIELD AVENUE, ALHAMBRA
Compare ASTH vs HCA, THC, EHC, FMS, DVA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ASTH
Astrana Health Inc
|
38.03 | 1.89B | 3.53B | 30.99M | 154.99M | 0.6134 |
|
HCA
Hca Healthcare Inc
|
421.21 | 91.33B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
263.46 | 21.67B | 21.46B | 2.65B | 3.35B | 19.23 |
|
EHC
Encompass Health Corp
|
121.04 | 11.99B | 6.07B | 793.80M | 464.40M | 5.9914 |
|
FMS
Fresenius Medical Care Ag Adr
|
22.23 | 11.88B | 22.44B | 1.35B | 2.03B | 1.9002 |
|
DVA
Davita Inc
|
181.33 | 11.68B | 13.84B | 1.10B | 1.49B | 10.42 |
Astrana Health Inc Stock (ASTH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-12 | Iniziato | Needham | Buy |
| 2025-04-01 | Iniziato | Barclays | Equal Weight |
| 2024-10-14 | Iniziato | TD Cowen | Buy |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2024-07-11 | Aggiornamento | Truist | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-02-26 | Iniziato | Jefferies | Buy |
| 2024-02-22 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-01-24 | Iniziato | Stifel | Buy |
| 2023-12-22 | Iniziato | Truist | Hold |
| 2023-10-17 | Iniziato | BTIG Research | Buy |
| 2023-04-12 | Iniziato | BofA Securities | Neutral |
| 2022-12-19 | Iniziato | Lake Street | Buy |
| 2022-09-21 | Iniziato | William Blair | Outperform |
| 2022-01-11 | Ripresa | Colliers Securities | Buy |
| 2021-08-12 | Iniziato | Barclays | Equal Weight |
Mostra tutto
Astrana Health Inc Borsa (ASTH) Ultime notizie
Astrana Health CEO Brandon Sim Surrenders Shares to Cover Tax Withholding on RSU Vesting - Kalkine Media
Enterprise value to revenue forward of Astrana Health Inc. – NASDAQ:ASTH - TradingView
Astrana Health (ASTH) exec surrenders shares to cover RSU taxes - Stock Titan
Here’s What Boosted Astrana Health (ASTH) in Q2 - finance.yahoo.com
Astrana (ASTH) Range: Moves 1.57% Higher to $39.35 in the Current Update; Boundary Watch - siam.in
Astrana Health (ASTH) Shares Just Moved, So What Is Going On? - Sahm
Astrana Health Director David Schmidt Executes Option Exercise and Sells Shares via Issuer Repurchase - Kalkine Media
Astrana Health (NASDAQ: ASTH) director sells 20K shares back to company - Stock Titan
ASTH | Astrana Health Inc. Common FinancialsRevenue Breakdown - quiverquant.com
Astrana Health (NASDAQ:ASTH) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Surges 7.99% to $40.81 — Key Levels to WatchHigh Beta Stocks - Vinanet
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call - Yahoo Finance
Astrana Health Inc (ASTH) Shares Surge 8.2% -- What GF Score of 85 Tells Investors - GuruFocus
Astrana Health (NASDAQ:ASTH) Rally Puts Growth In Focus - Kalkine Media
Astrana Health Jumps 7.1% After Truist Securities Maintains Buy - AlphaStreet
Astrana Health (ASTH) Surges 7.57% as Healthcare Services Stock Breaks HigherLow Risk Entry Stocks - Vinanet
Astrana Health (NASDAQ:ASTH) Shares Up 7.9%Still a Buy? - MarketBeat
Astrana Health (ASTH) Is Up 10.7% After Raising 2026 Guidance And Doubling Q2 Net IncomeHas The Bull Case Changed? - simplywall.st
ASTH Q2 2026 Earnings: 16.7% EPS Beat Drives OptimismSaaS Earnings Trends - vinanet.vn
Astrana Health: 81% Full-Risk And Profitable (NASDAQ:ASTH) - Seeking Alpha
Is Astrana Health Inc (ASTH) a Bargain After 8.1% Drop? GF Value Says Undervalued - GuruFocus
Astrana Health (NASDAQ:ASTH) Stock Price Down 5.7%What's Next? - MarketBeat
ASTRANA HEALTH, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $55 FROM $47 - Bitget
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Truist Securities Adjusts Price Target on Astrana Health to $55 From $47, Keeps Buy Rating - marketscreener.com
Astrana Health Inc. (ASTH) Stock Analysis: Exploring A 34.77% Potential Upside - DirectorsTalk Interviews
Astrana Health Submits Q2 2026 SEC Form 10-Q Detailing Financials and Share Information - Kalkine Media
Astrana Health, Inc. Q2 2026: Revenue $972.5M, EPS $0.4— 10-Q Summary - TradingView
Astrana Health (ASTH) grows Q2 2026 revenue to $972.5M with stronger profit - stocktitan.net
Results: Astrana Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - 富途牛牛
Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Astrana Health Management, Inc., for Alleged Violations of Meal & Rest Period Requirements - PR Newswire
Sei Investments Co. Raises Stake in Astrana Health, Inc. $ASTH - MarketBeat
Barclays Sticks to Their Buy Rating for Astrana Health (ASTH) - The Globe and Mail
Astrana Health (NASDAQ:ASTH) Raised to Buy at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Stock Rises On Cash Flow Strength And Deleveraging - simplywall.st
Astrana Health Inc. Stock 12‑Month Price Target Raised to $50.5, Implies 48% Upside - TradingView
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
A Quick Look at Today's Ratings for Astrana Health(ASTH.US), With a Forecast Between $41 to $53 - Moomoo
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts By Investing.com - Investing.com Nigeria
Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration Progress - Yahoo Finance
Enterprise value to revenue forward of Astrana Health Inc. – FWB:3AM - TradingView
Astrana Health (ASTH) Surges 5.22% as Momentum Builds Toward Key ResistanceSweep Order Flow - vinanet.vn
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook - The Globe and Mail
Astrana Health beats EPS estimates, raises EBITDA guidance By Investing.com - Investing.com Nigeria
Astrana Health, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Astrana Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ASTH) 2026-08-06 - Seeking Alpha
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts - Investing.com
Astrana Health Q2 Earnings Call Highlights - MarketBeat
ASTH Looks 59.4% Undervalued on GF Value™ - GuruFocus
Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates - Yahoo Finance
ASTRANA HEALTH ($ASTH) Releases Q2 2026 Earnings - Quiver Quantitative
Astrana Health Inc Azioni (ASTH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):